Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117899623 | 11789962 | 3 | F | 201205 | 20160906 | 20151201 | 20160916 | EXP | US-NOVOPROD-367324 | NOVO NORDISK | 60.00 | YR | A | M | Y | 113.38000 | KG | 20160916 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117899623 | 11789962 | 1 | PS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 1.8 MG, QD | Y | UNKNOWN | 22341 | 1.8 | MG | SOLUTION FOR INJECTION | QD | ||||
| 117899623 | 11789962 | 2 | C | METOPROLOL. | METOPROLOL | 1 | Y | 0 | |||||||||||
| 117899623 | 11789962 | 3 | C | LOSARTAN. | LOSARTAN | 1 | Y | 0 | |||||||||||
| 117899623 | 11789962 | 4 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Y | 0 | |||||||||||
| 117899623 | 11789962 | 5 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Y | 0 | |||||||||||
| 117899623 | 11789962 | 6 | C | GEMFIBROZIL. | GEMFIBROZIL | 1 | Y | 0 | |||||||||||
| 117899623 | 11789962 | 7 | C | GLYBURIDE. | GLYBURIDE | 1 | Y | 0 | |||||||||||
| 117899623 | 11789962 | 8 | C | ASPIRIN. | ASPIRIN | 1 | Y | 0 | |||||||||||
| 117899623 | 11789962 | 9 | C | RANITIDINE. | RANITIDINE | 1 | 150 MG, BID | 0 | 150 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117899623 | 11789962 | 1 | Type 2 diabetes mellitus |
| 117899623 | 11789962 | 2 | Hypertension |
| 117899623 | 11789962 | 3 | Hypertension |
| 117899623 | 11789962 | 4 | Hypercholesterolaemia |
| 117899623 | 11789962 | 5 | Hyperlipidaemia |
| 117899623 | 11789962 | 6 | Hypercholesterolaemia |
| 117899623 | 11789962 | 7 | Type 2 diabetes mellitus |
| 117899623 | 11789962 | 8 | Product used for unknown indication |
| 117899623 | 11789962 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117899623 | 11789962 | OT |
| 117899623 | 11789962 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117899623 | 11789962 | Abdominal pain | |
| 117899623 | 11789962 | Benign prostatic hyperplasia | |
| 117899623 | 11789962 | Blood glucose increased | |
| 117899623 | 11789962 | Diabetes mellitus inadequate control | |
| 117899623 | 11789962 | Fall | |
| 117899623 | 11789962 | Nausea | |
| 117899623 | 11789962 | Neck pain | |
| 117899623 | 11789962 | Non-consummation | |
| 117899623 | 11789962 | Pancreatitis chronic | |
| 117899623 | 11789962 | Pancreatolithiasis | |
| 117899623 | 11789962 | Vomiting | |
| 117899623 | 11789962 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117899623 | 11789962 | 1 | 20110510 | 20121001 | 0 |